Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Friedreich Ataxia
NCT01493973Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Jan 2013
- Primary completion
- Oct 2014
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in Friedreich ataxia (FA), sponsored by University of Naples Federico II. Started Jan 2013; status: completed.
02
Drugs
epoetin alfa
03
Conditions
Friedreich ataxia (FA)
Beyond the preview
Go deeper on NCT01493973.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01493973.